MEDIPOST Co., Ltd. (KOSDAQ:078160)
13,590
-90 (-0.66%)
Sep 18, 2025, 3:30 PM KST
MEDIPOST Revenue
MEDIPOST had revenue of 17.84B KRW in the quarter ending June 30, 2025, with 1.83% growth. This brings the company's revenue in the last twelve months to 72.17B, up 3.09% year-over-year. In the year 2024, MEDIPOST had annual revenue of 70.66B with 2.93% growth.
Revenue (ttm)
72.17B
Revenue Growth
+3.09%
P/S Ratio
6.46
Revenue / Employee
224.13M
Employees
322
Market Cap
466.47B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 70.66B | 2.01B | 2.93% |
Dec 31, 2023 | 68.64B | 4.44B | 6.92% |
Dec 31, 2022 | 64.20B | 9.34B | 17.03% |
Dec 31, 2021 | 54.86B | 6.23B | 12.82% |
Dec 31, 2020 | 48.62B | 2.81B | 6.14% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 5,031.69B |
Celltrion | 3,748.95B |
ALTEOGEN | 158.06B |
Yuhan | 2,165.44B |
SK Biopharmaceuticals | 620.28B |
Peptron | 5.18B |
PharmaResearch | 449.81B |
ABL Bio | 94.93B |